Institute of Medicine elects four new members from Penn
Four professors from Penn’s School of Medicine have been elected to the Institute of Medicine (IOM), one of the nation’s highest honors in biomedicine. Established in 1970 by the National Academy of Sciences, IOM recognizes professional achievement in the health sciences and serves as a national resource for independent analysis and recommendations on issues related to medicine, biomedical sciences, and health.
The new Penn members are: Deborah A. Driscoll, the Luigi Mastroianni, Jr. Professor and chair of the Department of Obstetrics and Gynecology; Caryn Lerman, the Mary W. Calkins Professor in the Department of Psychiatry and the Annenberg Public Policy Center; John R. Stanley, the Milton B. Hartzell Professor and chair of the Department of Dermatology; and Margaret Stineman, professor of Physical Medicine and Rehabilitation and professor of Epidemiology in the Center for Clinical Epidemiology and Biostatistics. The active IOM membership numbers 1,649 and the new inductees brings the number of Penn's representatives to 76.
“We are proud that four of our most distinguished and accomplished scientists have been named to one of the country's leading institutions,” says Arthur H. Rubenstein, executive vice president of the University of Pennsylvania for the Health System and dean of the School of Medicine. “Having Penn Medicine colleagues elected to this esteemed body is an extraordinarily significant honor.”
Penn physicists led by Bo Zhen have created hybrid light-matter particles that interact strongly enough to compute, pointing toward ultrafast, low-energy optical AI hardware.
Penn’s newest supercomputer is transforming research
Penn’s first campus-wide HPC and AI cluster, “Betty,” is expanding access to powerful computing, enabling groundbreaking projects, and fostering new collaborations across disciplines.
A bioengineered bean gum from the lab of Penn Dental’s Henry Daniell is found to reduce the levels of three microbes associated with head and neck squamous cell cancer to almost zero, without affecting the beneficial bacteria normally found in the mouth.
Fighting oral cancer with bioengineered chewing gum
Research led by Penn Dental’s Henry Daniell shows that antiviral and antibacterial chewing gums reduce the levels of three microbes linked to worse outcomes in oral cancers, paving the way for more effective and affordable therapies.
The performing arts at Penn: Process, practice, and purpose
In the vivid tapestry of performing arts groups at Penn, students prepare for their performances while simultaneously enriching their college experience.
